Login/Sign Up
Selected Pack Size:10
(₹169.88 per unit)
In Stock
(₹169.84 per unit)
In Stock
MRP ₹1887.5
(Inclusive of all Taxes)
₹283.1 Cashback (15%)
Comcapsy 700 mg/30 mg Tablet is an antineoplastic (anticancer) medication used to treat metastatic breast cancer. It contains Capecitabine and Cyclophosphamide, which work by damaging the genetic material of cancer cells and stopping their growth and multiplication. It may sometimes cause common side effects, such as nausea, vomiting, loss of appetite, diarrhoea, stomach pain, skin rash, weakness, tiredness, fever, mouth sores, and hair loss. Before taking this medication, inform your doctor if you are allergic to any of its ingredients or other cancer medicines, are pregnant or breastfeeding, or have any pre-existing medical conditions.
Provide Delivery Location
About Comcapsy 700 mg/30 mg Tablet
Comcapsy 700 mg/30 mg Tablet belongs to a group of medications called 'antineoplastic agents,' primarily used to treat metastatic breast cancer. Cancer occurs when cells in a specific body part grow and reproduce uncontrollably. The cancerous cells can attack and destroy surrounding healthy tissues and may sometimes spread to other areas of the body (known as metastasis).
Comcapsy 700 mg/30 mg Tablet contains two anticancer medications: Capecitabine (an antimetabolite) and Cyclophosphamide (an alkylating agent). Both drugs exhibit potential synergistic effects; Cyclophosphamide boosts the activity of an enzyme (thymidine phosphorylase) that helps convert Capecitabine into its active form, 5-fluorouracil. They work by damaging the genetic material of cancer cells to stop their growth and multiplication. Thus, Comcapsy 700 mg/30 mg Tablet helps treat cancer by killing cancer cells.
You are advised to take Comcapsy 700 mg/30 mg Tablet for as long as your doctor has prescribed it, depending on your medical condition. In some cases, you may experience common side effects, such as nausea, vomiting, loss of appetite, diarrhoea, stomach pain, skin rash, weakness, tiredness, mouth sores, hair loss, fever, low blood cell count, and hand-foot syndrome (swelling, redness, and peeling on palms and soles). If you experience any of these side effects, do not hesitate to report them clearly to your doctor.
Do not use Comcapsy 700 mg/30 mg Tablet if you are allergic to any of its ingredients, fluorouracil, other cancer medicines, or have severe kidney disease or bladder obstruction. Inform your doctor before taking Comcapsy 700 mg/30 mg Tablet if you had treatment with chemotherapy and radiation or have certain medical conditions, including metabolic disorders, chronic infection, a weakened immune system, urination problems, or heart, lung, liver, or kidney diseases. Tell your doctor if you are taking any blood thinners (warfarin) before using Comcapsy 700 mg/30 mg Tablet , as it may increase the risk of severe bleeding. Avoid taking Comcapsy 700 mg/30 mg Tablet if you are pregnant or breastfeeding, as it may cause harmful effects on the baby. Comcapsy 700 mg/30 mg Tablet may cause dizziness or vision problems, so avoid driving and operating machines until you are fully alert.
Uses of Comcapsy 700 mg/30 mg Tablet
Comcapsy 700 mg/30 mg Tablet is used to treat metastatic breast cancer. The detailed uses of Comcapsy 700 mg/30 mg Tablet are as follows:
Have a query?
Directions for Use
Medicinal Benefits
Comcapsy 700 mg/30 mg Tablet is an anticancer medication primarily used to treat metastatic breast cancer. It is also used in combination with other medicines to treat various types of cancer, as advised by a doctor, including colorectal, colon, stomach, pancreatic, and ovarian cancer. It contains Capecitabine (an antimetabolite) and Cyclophosphamide (an alkylating agent). Both work by damaging the genetic material of cancer cells to stop their growth and multiplication. Thus, Comcapsy 700 mg/30 mg Tablet effectively treats cancer by killing cancer cells.
How Comcapsy 700 mg/30 mg Tablet Works
Storage
What if I have taken an overdose of Comcapsy 700 mg/30 mg Tablet
Drug Warnings
Do not take Comcapsy 700 mg/30 mg Tablet if you are allergic to any of its ingredients, fluorouracil, other cancer medicines, or have severe kidney disease or bladder obstruction. Tell your doctor if you are taking prescription or non-prescription medications, vitamins, or herbal supplements to rule out any side effects and interactions. Additionally, inform your doctor before taking Comcapsy 700 mg/30 mg Tablet if you had treatment with chemotherapy and radiation or have certain medical conditions, including metabolic disorders (such as dihydropyrimidine dehydrogenase deficiency), chronic infection, a weakened immune system, decreased bone marrow function (such as leukopenia, anaemia, thrombocytopenia), dehydration, urination problems, or heart, lung, liver, or kidney diseases. Tell your doctor if you are taking any blood thinners (warfarin) before using Comcapsy 700 mg/30 mg Tablet , as it may increase the risk of severe bleeding. Exercise caution when using sharp objects like nail cutters and razors to minimize the risk of injury or bruising. Avoid taking Comcapsy 700 mg/30 mg Tablet if you are pregnant or breastfeeding, as it may cause harmful effects on the baby. Use birth control pills while taking Comcapsy 700 mg/30 mg Tablet and for 6 months after your last dose to prevent pregnancy. Comcapsy 700 mg/30 mg Tablet should be used with caution in elderly patients over 60 years. Comcapsy 700 mg/30 mg Tablet may cause dizziness or vision problems, so avoid driving and operating machines until you are fully alert.
Drug-Drug Interactions
Login/Sign Up
Drug-Food Interactions
Login/Sign Up
Diet & Lifestyle Advise
Habit Forming
Therapeutic Class
Alcohol
Caution
It is unknown whether alcohol interacts with Comcapsy 700 mg/30 mg Tablet . However, it is advisable not to consume alcohol as a precautionary measure.
Pregnancy
Unsafe
Comcapsy 700 mg/30 mg Tablet should not be used during pregnancy, as it may cause harmful effects on the baby. You are advised to avoid pregnancy by using birth control pills during treatment with Comcapsy 700 mg/30 mg Tablet and for 6 months after your last dose.
Breast Feeding
Unsafe
Comcapsy 700 mg/30 mg Tablet should not be taken during breastfeeding, as it passes into the breast milk and may harm the baby. You are advised to stop breastfeeding during treatment with Comcapsy 700 mg/30 mg Tablet and for 2 weeks after your last dose.
Driving
Caution
Comcapsy 700 mg/30 mg Tablet may cause dizziness and vision problems. Therefore, avoid driving and operating machines until you are fully alert.
Liver
Caution
Comcapsy 700 mg/30 mg Tablet may sometimes cause harm to the liver or increase bilirubin levels in the blood. If you have a history of liver disease, please inform your doctor before taking Comcapsy 700 mg/30 mg Tablet . Your doctor may need to adjust the dose of Comcapsy 700 mg/30 mg Tablet .
Kidney
Caution
Comcapsy 700 mg/30 mg Tablet may sometimes cause harm to the kidney. If you have a history of kidney disease, please inform your doctor before taking Comcapsy 700 mg/30 mg Tablet . Your doctor may need to adjust the dose of Comcapsy 700 mg/30 mg Tablet .
Children
Unsafe
Comcapsy 700 mg/30 mg Tablet should not be used by children under 12 years, as its safety and effectiveness have not been established in this age group.
Heart
Please inform your doctor if you have a heart problem before using Comcapsy 700 mg/30 mg Tablet .
Geriatrics
Consult your doctor
Please consult your doctor before giving Comcapsy 700 mg/30 mg Tablet to elderly people. Your doctor will prescribe Comcapsy 700 mg/30 mg Tablet if the benefits outweigh the risk.
Comcapsy 700 mg/30 mg Tablet is an anticancer medication primarily used to treat metastatic breast cancer. It is also used in combination with other medicines to treat various types of cancer, as advised by a doctor, including colorectal, colon, stomach, pancreatic, and ovarian cancer.
Comcapsy 700 mg/30 mg Tablet contains two anticancer medications: Capecitabine (an antimetabolite) and Cyclophosphamide (an alkylating agent). Both drugs exhibit potential synergistic effects; Cyclophosphamide boosts the activity of an enzyme (thymidine phosphorylase) that helps convert Capecitabine into its active form, 5-fluorouracil. They work by damaging the genetic material of cancer cells to stop their growth and multiplication. Thus, Comcapsy 700 mg/30 mg Tablet helps treat cancer by killing cancer cells.
Comcapsy 700 mg/30 mg Tablet may cause common side effects such as nausea, vomiting, loss of appetite, diarrhoea, stomach pain, skin rash, weakness, tiredness, mouth sores, hair loss, fever, low blood cell count, and hand-foot syndrome (swelling, redness, and peeling on palms and soles). If you experience any of these side effects, do not hesitate to report them clearly to your doctor. Your doctor may suggest lifestyle changes, medications, and supportive therapies to help reduce discomfort and improve your quality of life.
Do not stop taking Comcapsy 700 mg/30 mg Tablet on your own without consulting your doctor, as it can affect your treatment and recovery. You are advised to take Comcapsy 700 mg/30 mg Tablet for as long as your doctor has prescribed it, depending on your medical condition, for effective treatment of cancer.
Yes, Comcapsy 700 mg/30 mg Tablet may impair fertility by temporarily stopping sperm production in men and disrupting normal menstrual periods in women. Therefore, consult your doctor for advice before taking Comcapsy 700 mg/30 mg Tablet if you are planning to have a child. Also, it is important to use birth control pills while taking Comcapsy 700 mg/30 mg Tablet and for 6 months after your last dose to prevent pregnancy.
Comcapsy 700 mg/30 mg Tablet might cause myelosuppression (reduced bone marrow function) leading to a decrease in white blood cells. This could lead to an increased risk of infections. You are advised to get regular blood tests while taking Comcapsy 700 mg/30 mg Tablet .
Yes, Comcapsy 700 mg/30 mg Tablet contains two chemotherapy medicines: Capecitabine, which is an antimetabolite, and Cyclophosphamide, which is an alkylating agent. They work by destroying cancer cells.
Comcapsy 700 mg/30 mg Tablet may cause weight loss due to decreased appetite and may also be a result of the underlying cancer. Please consult your doctor if you experience significant weight loss while using Comcapsy 700 mg/30 mg Tablet .
Country of origin
Manufacturer/Marketer address
Buy best Neoplastic Disorders products by
Intas Pharmaceuticals Ltd
Dr Reddy's Laboratories Ltd
Natco Pharma Ltd
Celon Laboratories Pvt Ltd
Cipla Ltd
Sun Pharmaceutical Industries Ltd
BDR Pharmaceuticals Internationals Pvt Ltd
Adley Formulations
Admac Lifesciences(Oncology)
Alkem Laboratories Ltd
Neon Laboratories Ltd
Glenmark Pharmaceuticals Ltd
United Biotech Pvt Ltd
Halsted Pharma Pvt Ltd
Emcure Pharmaceuticals Ltd
Zydus Healthcare Ltd
Zydus Cadila
Samarth Life Sciences Pvt Ltd
Mylan Pharmaceuticals Pvt Ltd
Hetero Drugs Ltd
GLS Pharma Ltd
Axiommax Oncology Pvt Ltd
Fresenius Kabi India Pvt Ltd
Hetero Healthcare Pvt Ltd
Torrent Pharmaceuticals Ltd
Pfizer Ltd
Getwell Life Sciences India Pvt Ltd
Khandelwal Laboratories Pvt Ltd
Lupin Ltd
Adley Pharmaceuticals Ltd
Cadila Healthcare Ltd
Aureate Healthcare
Novartis India Ltd
Therdose Pharma Pvt Ltd
RPG Life Sciences Ltd
Abbott India Ltd
Biochem Pharmaceutical Industries Ltd
Delarc Pharmaceuticals Pvt Ltd
Aimcad Biotech Pvt Ltd
Reliance Formulation Pvt Ltd
Shilpa Medicare Ltd
Wembrace Biopharma Pvt Ltd
Zee Laboratories Ltd
Msn Laboratories Pvt Ltd
Amps Biotech Biotech Pvt Ltd
Astra Zeneca Pharma India Ltd
Getwell Oncology Pvt Ltd
Caitlin Oncology
Medaegis Biotek Pvt Ltd
Dabur India Ltd
Del Trade International Pvt Ltd
MEDICAMEN BIOTECH LTD
Medion Biotech Pvt Ltd
Oncostar Pharma Pvt Ltd
Panacea Biotec Ltd
Sarabhai Chemicals (India) Pvt Ltd
Bhardwaj India Pvt Ltd
Getwell Pharmaceutical Pvt Ltd
Cytogen
Lucien Life Sciences
Symbion Lifescience
Bangalore Pharmaceutical and Research Laboratory Pvt Ltd (BPRL)
Cadila Pharmaceuticals Ltd
Miracalus Pharma Pvt Ltd
Vhb Life Sciences Inc
Allieva Pharma Pvt Ltd
Amneal Healthcare Pvt Ltd
Ipca Laboratories Ltd
Zuvius Lifesciences Pvt Ltd
Eli Lilly and Company (India) Pvt Ltd
Eris Life Sciences Ltd
Johnson & Johnson Pvt Ltd
Maximal Healthcare Pvt Ltd
Admac Pharma Ltd
Akumentis Healthcare Ltd
Biocon Ltd
Bruck Pharma Pvt Ltd
Caitlin Biotech Pvt Ltd
Ferring Pharmaceuticals Pvt Ltd
Fresenius Kabi Oncology Ltd
Hilfen Pharmaceuticals Pvt Ltd
Medicamen Biotech Ltd
Sayre Therapeutics Pvt Ltd
Zuventus Healthcare Ltd
Boehringer Ingelheim India Pvt Ltd
Selway Lifesciences Pvt Ltd
Trikem Remedies Llp
Adley Oncology
Corona Remedies Pvt Ltd
Eisai Pharmaceuticals India Pvt Ltd
GlaxoSmithKline Pharmaceuticals Ltd
Gynofem Healthcare Pvt Ltd
Hillrock Biotech Pvt Ltd
Janssen Pharmaceuticals Pvt Ltd
Jodas Expoim Pvt Ltd
Mankind Pharma Pvt Ltd
Merck Ltd
Oncobiotek Drugs Pvt Ltd
Pharm Products Pvt Ltd
Rhone Poulenc Rorer India Pvt Ltd